• Gasdermin C Drives PDAC Stemness and Immune Evasion

  2026-08-17

  A 2024 Advanced Science study identifies Gasdermin C (GSDMC) as a nuclear regulator of pancreatic ductal adenocarcinoma stemness, metastasis, and immune evasion, independent of canonical pyroptosis. The work connects ADAM17-mediated GSDMC cleavage to transcriptional reprogramming and shows that blocking cleavage or nuclear translocation can improve responses to KRASG12D inhibition and PD-1 checkpoint blockade in preclinical models.

• Phosbind Acrylamide for Protein Phosphorylation Analysis

  2026-08-17

  Phosbind Acrylamide enables antibody-free visualization of phosphorylation-dependent mobility shifts in proteins, making it useful for kinase assays, signaling studies, and plant protein validation. This practical guide connects the reagent to the TaCKX11-D–TaMPK3/6 wheat study while emphasizing gel design, controls, and troubleshooting.

• Lysoptosis: Serpins and Cathepsin-Dependent Cell Death

  2026-08-16

  The reference study establishes lysoptosis as an evolutionarily conserved lysosome-dependent cell-death pathway that emerges when intracellular serpins fail to restrain cysteine proteases. By comparing Caenorhabditis elegans with mouse and human epithelial models, it connects lysosomal membrane permeabilization, cathepsin release, and predominantly cathepsin L-driven proteolysis into a distinct mechanistic framework.

• Clodronate Liposomes: Reliable Macrophage Depletion

  2026-08-15

  Learn how Clodronate Liposomes (SKU K2721) can clarify macrophage-dependent effects in viability, proliferation, and cytotoxicity studies. This scenario-based guide covers mechanism, route selection, controls, optimization, interpretation, and practical vendor-selection criteria.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflows

  2026-08-14

  Use dual fluorescence to separate mRNA uptake from protein expression in a single experiment. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) provides a practical benchmark for nanoparticle validation, macrophage and β-cell delivery studies, and quantitative optimization of transfection workflows.

• Phos binding reagent (Phosbind) acrylamide

  2026-08-14

  Learn how Phos binding reagent (Phosbind) acrylamide, SKU F4002, can complement viability and cytotoxicity assays with antibody-independent protein phosphorylation analysis. This scenario-based guide covers pathway interpretation, gel preparation, controls, and practical vendor-selection criteria.

• Inflammation in Ischemic Stroke: Biomarkers and Treatment

  2026-08-13

  Xiao et al. (2025) provide a translational review linking early neuroinflammation, blood–brain barrier disruption, peripheral immune activation, biomarkers, and treatment development in ischemic stroke. Its main contribution is an integrated framework that clarifies why inflammatory markers have diagnostic and prognostic value while also highlighting the importance of disease stage, biological context, and therapeutic timing.

• Annexin A2 Autoantibodies in Pediatric Nephrotic Syndrome

  2026-08-13

  The reference study identifies annexin A2 autoantibodies as a potential pathogenic factor in a subset of children with minimal change disease or non-genetic focal segmental glomerulosclerosis. Its experiments connect antibody-mediated disruption of PTP1B–annexin A2 regulation to Tyr24 phosphorylation, Rho signaling, podocyte cytoskeletal injury, and proteinuria.

• Amphotericin B: Mechanism and Research Workflow

  2026-08-12

  Amphotericin B is a polyene antifungal antibiotic that targets fungal membrane sterols and can disrupt membrane integrity. This research dossier explains its sterol-dependent activity, immune signaling, animal-model evidence, assay parameters, storage requirements, and experimental limitations.

• LMO2–LDB1 Signaling in Acute Myeloid Leukemia

  2026-08-12

  The reference study identifies an LMO2/LDB1 protein complex as a functional driver of acute myeloid leukemia (AML), rather than treating LMO2 only as a prognostic marker or lineage regulator. Through genetic perturbation, protein-interaction analysis, transcriptomics, ChIP-seq, and in vivo validation, the authors show that LDB1 supports AML-cell survival and that LMO2 partially rescues the effects of LDB1 loss.

• N-octanoyl-L-Homoserine lactone in QS Assays

  2026-08-11

  Build more reproducible quorum-sensing, biofilm, and host-response experiments with C8-HSL, a water-insoluble bacterial signaling molecule suited to controlled solvent dosing. This guide connects microbial pathogenicity research with a recent lung cancer model and provides practical workflows, assay controls, and troubleshooting strategies.

• U0126: MEK1/2 Inhibition for ERK and Tau Assays

  2026-08-11

  U0126 provides a practical way to test whether MEK1/2-driven ERK signaling links disease-associated stress to tau phosphorylation, aggregation, and cell death. This workflow combines pathway pharmacology, neuronal phenotyping, formulation control, and troubleshooting guidance for reproducible cellular studies.

• Wortmannin PI3K Inhibitor: Workflow & Troubleshooting

  2026-08-10

  Turn PI3K inhibition into a more interpretable experiment with practical dosing, autophagy-focused readouts, and controls for MLCK-related confounding. This guide connects Wortmannin workflows to macrophage host–pathogen studies, apoptosis assays, and pancreatic cancer xenograft research while emphasizing reproducibility and assay limitations.

• FBXO22 Degraders and 2-PCA Recruitment Ligands

  2026-08-09

  This preprint introduces chemical probes that distinguish direct FBXO22 degradation from FBXO22 recruitment in targeted protein degradation. Its most notable advances are the selective degrader AHPC(Me)-C6-NH2, the chain-length dependence of diamine-mediated self-degradation, and 2-pyridinecarboxaldehyde as a reversible electrophilic recruitment handle for degrading BRD4 and CDK12.

• SB 431542 in Intestinal Signaling Research

  2026-08-08

  Explore how SB 431542 functions as an ALK5 inhibitor for dissecting TGF-β signaling in intestinal epithelial homeostasis. This article emphasizes phenotype-level interpretation, rescue experiments, receptor selectivity, and assay design beyond routine pathway inhibition.

16873 records 1/1125 page Next 12345 下5页 Last page